Literature DB >> 438970

Quantitative structure-activity relationships and dipole moments of anticonvulsants and CNS depressants.

E J Lien, R C Liao, H G Shinouda.   

Abstract

The anticonvulsant and CNS-depressant activities of 16 commercially available antiepileptics were subjected to regression analysis. For the maximal electroshock seizure test and pentylenetetrazol seizure threshold test, good correlations were obtained only after diazepam, clonazepam, and carbamazepam were deleted; for the median toxic dose (rotorod ataxia), all 16 compounds can be included in one single equation using log MW, log P, and dipole moment (mu) terms. For the anticonvulsant activities of 7-substituted 1,4-benzodiazepinones, a parabolic equation of pi combined with the Hammett sigma constant gave fair correlations for most derivatives examined in three different tests. Based upon the correlations obtained, further molecular modifications are suggested. The dipole moments of seven clinically used antiepileptic drugs were measured in 1,4-dioxane for the first time.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 438970     DOI: 10.1002/jps.2600680418

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  Applications of rule-induction in the derivation of quantitative structure-activity relationships.

Authors:  M A-Razzak; R C Glen
Journal:  J Comput Aided Mol Des       Date:  1992-08       Impact factor: 3.686

2.  Synthesis and Anticonvulsant Evaluation of some New 6-(Substituted-phenyl)thiazolo[3,2-b][1,2,4]triazole Derivatives in Mice.

Authors:  Xian-Qing Deng; Ming-Xia Song; Guo-Hua Gong; Shi-Ben Wang; Zhe-Shan Quan
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

3.  Synthesis and anticonvulsant properties of 1-(amino-N-arylmethanethio)-3-(1-substituted benzyl-2, 3-dioxoindolin-5-yl) urea derivatives.

Authors:  Nadeem Siddiqui; M Shamsher Alam; James P Stables
Journal:  Eur J Med Chem       Date:  2011-03-10       Impact factor: 6.514

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.